52 (131-139 ) 1385

-
))(( 1 -47 1384
)*(M.Sc.

)**(M.D.

)***(M.Sc.

)****(B.S.

: -
.
.
1384 .
: . 1 47
1371 1384 3 . 48
. .
: 407 13/5 43 . -
) (1371 -1374 364 12 2 182 .

. 1 1/6
1/35 1/5 1/22 1/3 . 20 11/5
2/1 3/38 . ) .(P<0/000
.
:
.
: Vancouver group

Medline Pub Med

) Institute for Scientific Information(ISI

) (1

*
**
***
( 84/7/24 :

84/10/4 :

131

: -

****
84/11/18 :

52 1385

ISI -

).(2

. .

)) (Impact Factor(

3 4 )

) .(3

90

) (Evidence Based Medicine

) 4 .(6

) 11 .(13

)7 .(9

) 14 .(16

1384

)101 .(3

1384 .

52 132 1385

Pvalue )

. 1 47

( .

1371 1384

) (18-17 48 .

.



.

.
) (Vancouver ) .(19
3 .

.
.
T-test .

.
Nested

case control

407 .

.Cross-sectional

11 - 43

. 12 -14

) 1(KAP

) 15 (1376 -

2 .

1. Knowledg Attitude Practice

133

52 1385

5/8 3/2 .

. 3 1

82 . 21

52

. 3

. .

) .(1

2/3

) 95

17

. 12

. 39

2 4 3

. 95

Cross Sectional 5

. 3
:1 1-47 - 1384




.

).(%
)(.
).(%
.
.
.
.
)(%

43
1371-47
1-11
5/8 3/2
78/6
1/4 0/67
)1(2/3
1 1/6
62
17
)22(51
)4( 9
)0( 0
60

182
1375-79
12-35
9/8 2/9
80
2/6 1/97
16/5
1/35 1/5
69/2
)43(23/6
)4(2/2
)2(1/1
)0( 0
31/3

182
80-84
35-47
**14/5 3/4
82
3 1/46
20
*1/22 1/3
69
)37(20/4
)7(3/9
11(6/1
)0( 0
31
* NS
** P<0.01

: 2 1-47 - 1384








)(


)(%

N = 43
1371-47
)9 (20/9
)0( 0
)15 (34/9
)0( 0
)1(2/3
)0( 0
)17 (39/5
)1(2/3
)0( 0
48

N = 182
1375-79
)62 (39/5
)22(12
)25 (13/6
)20 (11
)14 (7/6
)8 (4/4
)8(4/4
)13 (7/1
)0( 0
35

N = 182
1380-84
)71(39/2
)37 (20/4
)25 (13/9
)21 (11/6
)12 (6/7
)7 (3/9
)3 (1/7
)5 (2/8
)1 (0/8
37

52 134 1385

: 3 1-47 - 1384




.
P value .
.



.
.
.



.
.

N = 43
1371-47

N = 182
1375-79

N = 182
1380-84

)243 (55/8
)9 (21
)3( 7
)7 (16/2
8/8 0/9

)64 (35/3
)91 (50
)15 (8/2
)12 (6/6
3/8 1

)64 (35/3
)93 (51/4
)13 (7/2
)11(6/1
* 3/6 9/9

)23(53
)9 ( 2
)3 ( 7
)8(19

)60 (32/9
)11 (6
)6 (3/3
)105(57/7

)66 (36/4
)10(5/5
)3(1/7
)1,2 (56/4

)23 (53
)7 (16
)8 (19
)5 (12

)96 (52/8
)45 (24/7
)6 (3/3
)35 (19/2

)91 (50/3
53 (29/3
)2 (1/1
)35 (19/2
* NS

: 4 1-47 - 1384




P value .
.
.
.
.
.
.
.
.
.
.
.
.
.
2 .
3 .
.








Spelling

N = 43
1371-47

N = 182
1375-79

N = 182
1380-84

)22(51
)3( 7
)8 (19
)8 (19
)12 (4
)13 (30
)8 (19
)0 ( 0
)22 (51
)17(39/5
)0( 0
)0( 0
)0( 0
)0( 0
)3 ( 7
)12(28
)11(25/5

)157 (85/3
)6 (3/3
)4(2/2
)2 (1/1
)13 (7/2
)133 (37/1
)28 (15/4
)5(2/7
)16 (8/8
)40 (22
)69 (37/9
)2 (1/1
)9 (4/9
)6 (3/3
)2 (1/1
)15 (8/2
)4 (2/2
)8(4/4

)162 (89/5
)4 (2/2
)1 (0/6
)1 (0/6
)13 (7/2
)152 (84/0
)14(7/7
)11 (6/1
)1 (1/7
)50 (27/6
)74 (40/9
)0( 0
)3(1/7
)5 (2/8
)10 (5/5
)2 (1/1
)4(2/2

)20 (46/5
)10(23
)13 (30/5

)144 (79/1
)7 (3/08
)30 (16/5

)130 (71/8
)13 (7/2
)38 (21

5/3 5/5
0/4 1/8
)14 (32/5
)4 (9/5
)22 (51
)3 ( 7

15/09 8/5
1/75 2/6
)17 (9/3
)0( 0
)99 (54/4
)66 (36/3

* 20 11/5
* 2/1 3/38

)5(2/8
)1 (0/6
)156 (86/2
)19 (10/5
* NS
** P<0.000

135

52 1385

5 )

( .

. 47

12 17

).(5

4 spss

) .(22

) (1

) (21

) 207(

).(22

) (Evidence Level 5 .

) (Level 1

) 1 (RCT

1. Random Clinical Trial

52 136 1385

. 7 8

) (Research Designs .

Correlational .

) (

137

. Iran medex
Pars medline CD

52 1385

) .(23-24

.
-

.
.

.
.

.1 .

1374 20 1 -

6. NHS Ceuter for reviews and dissemination

setting evidence into practice effective
health care 1999; 5(1): 1-16.

. 1-3
.2 .

.7

2004

/3/28 84

34 1383 .66-60

84/1/21

.3 .

. 83

.8

1992 2002 Impact

. Factor 1382 27

/118 4/ 1384/3/22 1 . 5
.9 :

2 .139-143
4. Institute of Medicine. Clinical practice

guidelines: directions for a new program

. 1384

National Academy Press, Washington,

DC, 1990.

5. Guyatt GM, Sackett DC, Sinclar JC,

Hayward R, Cook DY, Cook RJ, for the
Vidence-Based Medicine working Group.
Users guides to the medical literetive IX.
A method for grading nealth care

.220-212
.10 .
:
.

- - .1377

recommendations JAMS 1995;246:1800-4.

52 138 1385

.11

.17

1376 . 21 3 .18 -24

. .
1383 .452 -429

.12 . .
-

.18 .

30 1380

. 80 -86

.1380
19. International committee of medicine

.13 .
) . (Systematic review

uniform reguirements for manuscript

1383 28 -1 .15 -18

submitted to biomedical journals. Br.

Med J. 1991; 302: 338-341.

.14
1382 1383

.20 3/28 84 84/1/21

-1384 -29 -1

.79-80

15. Emerson LD, Colditz GA. Use of

.21

statistical Analysis in the New England

journal Medicine in:Bailar LC, Mosteiler

1383 1383

F. Medical uses of statistics NEJM

. 14

Books, Medical society Massachusetts

.22 3/28 84 84/1/21

1986; 27-38.

16. Mary LV, Andrew LR, Michael OR,

Amy MS, Michelle JS, Michael DN. The

.
.23 -

quality of Ropndomized controlled trials

in major Anesthesiology journals. Anesth

-1358-72 1

Analg 2005; 100: 1759- 64.

.1374
.24 -
) (CD

.1372-78
o

139

52 1385